YUZ-29809-77215
2 vaccinations
8 coded responses
22 check-ins
8 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 441 / OH
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
-
2021-04-08
Survey response — day 14, dose 1MedDRA: Asthma, Dyspnoea, Oropharyngeal pain, Pre-existing disease, Throat irritation — Feeling: Good · Be unable to do your normal daily activitiesFree text: Awaken with sore scratchy throat. Short of breath Probably due to asthma. Took a albuterol/ ipratopium breathing treatment, which alleviated the issue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Dose 2 — Pfizer-BioNTech
-
2021-04-15
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-17
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Wheezing — Feeling: Good · Be unable to do your normal daily activitiesFree text: Cough and wheezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-20
-
2021-04-22
Survey response — day 7, dose 2MedDRA: Dyspnoea, Wheezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Wheezing and short of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
-
2021-05-06
Survey response — day 21, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Asthma not under control after last dose of prednisoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-15
-
2021-05-20
Survey response — day 35, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Asthma flaring upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-15
Survey response — 3 months, dose 2MedDRA: Asthma, Pre-existing disease, Respiratory tract infection viral — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Asthma flare up with some kind of viral respiratory issueMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-14
Survey response — 6 months, dose 2MedDRA: Vocal cord dysfunction — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Vocal cord dysfunctionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-14
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-10-18
-
2022-04-18
Survey response — 12 months, dose 2MedDRA: Asthma, Cough, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Asthma flare up recently and currently still experiencing lingering coughMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-15 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-14 | Unsuccessful | |
| 2022-04-18 | Unsuccessful |
Free text
Release 7 — day 14, dose 1
Symptoms: Awaken with sore scratchy throat. Short of breath Probably due to asthma. Took a albuterol/ ipratopium breathing treatment, which alleviated the issue.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Cough and wheezing
Release 7 — day 7, dose 2
Systemic reaction (other): Wheezing and short of breath
Release 8 — day 21, dose 2
Symptoms: Asthma not under control after last dose of prednisone
Release 8 — day 35, dose 2
Symptoms: Asthma flaring up
Release 9 — 3 months, dose 2
Symptoms: Asthma flare up with some kind of viral respiratory issue
Release 10 — 6 months, dose 2
Symptoms: Vocal cord dysfunction
Release 11 — 12 months, dose 2
Symptoms: Asthma flare up recently and currently still experiencing lingering cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Respiratory tract infection viral | ✓ | · | ✓ |
| SD | Throat irritation | ✓ | ✓ | ✓ |
| SD | Vocal cord dysfunction | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Wheezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release